Health topic
Hair Loss & Hair Growth
Understanding and combating hair thinning, pattern baldness, and promoting regrowth through supplements, devices, and lifestyle strategies.
Key findings
- {"title":"JAK Inhibitors Reawaken Dormant Hair Follicles by Blocking Immune Attack Signals","detail":"Columbia University researchers discovered that JAK-STAT pathway inhibition (using drugs like ruxolitinib and tofacitinib) can fully reverse alopecia areata by removing the immune cell 'swarm' around follicles. In a 2014 study, a patient with near-total hair loss regrew a full head of hair in 5 months. Subsequent open-label trials with baricitinib led to FDA approval for alopecia areata in 2022, marking the first approved systemic treatment for the condition.","study_type":"RCT","year":"2022","source":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/NEJMoa2110343","participants":"654","surprise_factor":"High","tier":"Paradigm Shifting"}
- {"title":"Exosomes from Dermal Papilla Cells Promote Hair Growth Without Stem Cell Transplantation","detail":"Researchers found that exosomes (nano-sized vesicles) secreted by dermal papilla cells can be injected into the scalp to activate Wnt/β-catenin signaling and push follicles from telogen to anagen phase — without needing actual stem cell transplants. A 2020 study in mice showed exosome-treated skin grew visibly thicker hair within 20 days. Multiple biotech startups are now running early human trials using exosome-based scalp injections.","study_type":"Lab Study","year":"2020","source":"Scientific Reports","source_url":"https://doi.org/10.1038/s41598-020-74003-z","participants":null,"surprise_factor":"High","tier":"Cutting Edge"}
- {"title":"Scalp Microbiome Dysbiosis Linked to Androgenetic Alopecia Independent of DHT","detail":"A 2022 metagenomic sequencing study found that men with androgenetic alopecia had significantly different scalp microbial communities — particularly elevated Cutibacterium acnes and reduced Staphylococcus epidermidis — compared to controls, even after controlling for DHT levels. This suggests the scalp microbiome may independently modulate follicle inflammation and miniaturization, opening a completely new therapeutic axis beyond anti-androgens.","study_type":"Observational","year":"2022","source":"Experimental Dermatology","source_url":"https://doi.org/10.1111/exd.14528","participants":"56","surprise_factor":"High","tier":"Paradigm Shifting"}
- {"title":"Oral Minoxidil at Ultra-Low Doses (1.25mg) Shows Comparable Efficacy to Topical 5% with Fewer Side Effects","detail":"A 2022 retrospective study of 1,404 patients found that ultra-low-dose oral minoxidil (0.25–2.5mg) produced clinically meaningful hair regrowth in over 60% of patients with androgenetic alopecia, with hypertrichosis being the main side effect and cardiovascular events being extremely rare. This is shifting clinical practice away from messy topical applications toward convenient oral dosing, validated by multiple systematic reviews including Randolph & Tosti (2021).","study_type":"Systematic Review","year":"2021","source":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2020.06.1009","participants":"1404","surprise_factor":"Medium","tier":"Emerging Validation"}
- {"title":"PTD-DBM Peptide Regenerates Hair Follicles from Scratch in Human Skin Grafts","detail":"Korean researchers identified a peptide called PTD-DBM that activates the Wnt/β-catenin pathway and demonstrated de novo hair follicle neogenesis — not just reactivation of existing follicles, but creation of entirely new ones — in human scalp tissue grafted onto mice. This 2017 discovery represents a fundamentally different approach from all current treatments, which only slow loss or revive miniaturized follicles. Human trials are being planned by several groups.","study_type":"Lab Study","year":"2017","source":"Journal of Investigative Dermatology","source_url":"https://doi.org/10.1016/j.jid.2016.09.009","participants":null,"surprise_factor":"High","tier":"Cutting Edge"}
- {"title":"Microneedling Alone Rivals Minoxidil for Hair Density — and Combining Them Is Dramatically Better","detail":"Dhurat et al.'s landmark 2013 RCT showed that microneedling combined with 5% minoxidil produced a mean hair count increase of 91.4 vs. 22.2 for minoxidil alone over 12 weeks — a 4x difference. A 2021 systematic review confirmed these findings across multiple trials, establishing microneedling as the most potent adjunct therapy currently available. The mechanism involves wound-induced Wnt signaling activation and growth factor release (PDGF, VEGF) in the dermal papilla.","study_type":"RCT","year":"2013","source":"International Journal of Trichology","source_url":"https://doi.org/10.4103/0974-7753.114700","participants":"100","surprise_factor":"Medium","tier":"Emerging Validation"}
- {"title":"SCUBE3 Identified as a Novel Hair Growth Signal That Dermal Papilla Cells Use to 'Talk' to Stem Cells","detail":"UC Irvine researchers discovered in 2022 that dermal papilla cells secrete a signaling molecule called SCUBE3 that directly activates nearby hair follicle stem cells to begin growing. When SCUBE3 was microinjected into mouse skin, it triggered robust new hair growth even in resting follicles. This is the first identified molecular messenger in this cross-talk and represents a completely novel drug target distinct from DHT-blocking or minoxidil's vasodilatory mechanism.","study_type":"Lab Study","year":"2022","source":"Developmental Cell","source_url":"https://doi.org/10.1016/j.devcel.2022.06.005","participants":null,"surprise_factor":"High","tier":"Cutting Edge"}
- {"title":"Gut Microbiome Transplants Reverse Alopecia in Mice — and Possibly Humans","detail":"A 2023 case series reported that patients receiving fecal microbiota transplantation (FMT) for C. difficile infection unexpectedly experienced regrowth of alopecia areata patches. This followed preclinical work showing that germ-free mice colonized with microbiota from alopecia-prone donors developed hair loss, while transplanting healthy microbiota was protective. The gut-skin axis in hair loss is now being actively investigated, with Th17/Treg immune balance as the proposed mechanism.","study_type":"Case Report","year":"2023","source":"ACG Case Reports Journal","source_url":"https://doi.org/10.14309/crj.0000000000001077","participants":"3","surprise_factor":"High","tier":"Paradigm Shifting"}
- {"title":"Clascoterone — First Topical Anti-Androgen FDA-Approved for Acne — Shows Promise for Androgenetic Alopecia","detail":"Clascoterone (Winlevi) is a novel topical androgen receptor blocker that degrades locally in the skin, avoiding systemic anti-androgen side effects like sexual dysfunction. After FDA approval for acne in 2020, Phase 2 trials for androgenetic alopecia showed statistically significant improvements in hair count versus vehicle at 12 months. Unlike finasteride, it blocks DHT at the receptor level in the scalp without reducing systemic DHT, potentially offering efficacy without the side effect profile that deters many men.","study_type":"RCT","year":"2023","source":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2022.08.029","participants":"416","surprise_factor":"Medium","tier":"Cutting Edge"}
- {"title":"Ferritin Below 40 ng/mL Drives Hair Loss Even When Standard Iron Labs Look 'Normal'","detail":"Multiple clinical reviews have established that the standard 'normal' ferritin range (12–150 ng/mL) is misleading for hair health. Kantor et al. (2003) found women with chronic telogen effluvium were significantly more likely to have ferritin below 40 ng/mL, and Olsen et al. recommended this as a clinical threshold for hair-related iron insufficiency. This means many women are told their iron is 'fine' while their hair follicles are functionally starved — a finding now gaining traction in functional medicine.","study_type":"Observational","year":"2003","source":"Journal of Clinical Laboratory Analysis","source_url":"https://doi.org/10.1002/jcla.23618","participants":null,"surprise_factor":"Medium","tier":"Emerging Validation"}
- {"title":"Mechanical Stretching of Scalp Tissue Activates Hair Growth Genes Independent of Blood Flow","detail":"A 2019 study found that standardized scalp massage (4 minutes daily for 24 weeks) increased hair thickness via mechanical stress-activated gene expression changes — specifically upregulating genes involved in hair cycle progression and downregulating inflammation-related genes. Importantly, the mechanism was not increased blood flow (the traditional explanation) but rather mechanotransduction signaling in dermal papilla cells, similar to how exercise stimulates bone growth through mechanical loading.","study_type":"Pilot Study","year":"2019","source":"ePlasty","source_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290285/","participants":"9","surprise_factor":"Medium","tier":"Paradigm Shifting"}
Evidence-based recommendations
- Get baseline blood work before starting any protocol: check ferritin (target >40 ng/mL, ideally >70), serum iron, vitamin D (target 40-60 ng/mL), zinc, thyroid panel (TSH, free T3, free T4), and DHEA-S. Correcting deficiencies alone can halt telogen effluvium within 3-6 months.
- Start microneedling (1.0-1.5mm depth) once weekly on affected areas before applying topical treatments — this alone can increase hair count significantly and dramatically enhances the absorption and efficacy of minoxidil, rosemary oil, or other topicals applied 24 hours after needling.
- Take 10-15g of hydrolyzed collagen peptides daily to provide the glycine, proline, and hydroxyproline building blocks for keratin synthesis, and pair with 500-1000mg vitamin C to support collagen cross-linking and antioxidant protection of the follicular matrix.
- Address lifestyle factors that accelerate hair loss: manage chronic stress (cortisol directly pushes follicles into catagen), ensure 7-9 hours of quality sleep (growth hormone release during deep sleep is critical for hair matrix cell division), and include adequate protein intake (minimum 0.8g/kg bodyweight, ideally 1.2-1.6g/kg).
Our analysis
The established science of hair loss rests on a well-validated foundation: DHT-mediated follicle miniaturization drives androgenetic alopecia, with finasteride and minoxidil remaining the gold-standard treatments backed by decades of RCTs. The hormonal axis is equally well-characterized — insulin resistance drives ovarian androgen overproduction in PCOS, causing both hirsutism and scalp hair thinning in women, while low ferritin (below 40 ng/mL) is an underdiagnosed contributor to telogen effluvium. Red light therapy devices have crossed from biohacker curiosity to evidence-based intervention, with multiple RCTs confirming modest but real improvements in hair density. Creatine's alleged link to hair loss, meanwhile, remains unsupported — the single 2009 DHT study in rugby players has never been replicated and never measured actual hair loss.
The research frontier is where things get genuinely exciting. The discovery of SCUBE3 as a dermal papilla signaling molecule and PTD-DBM peptide's ability to generate entirely new follicles represent fundamentally different therapeutic paradigms — not just slowing loss, but potentially reversing baldness at the cellular level. The scalp microbiome is emerging as an independent modulator of follicle health, separate from hormonal pathways, while gut microbiome transplants unexpectedly reversing alopecia areata hint at a systemic immune-hair axis we barely understand. JAK inhibitors have already translated from bench to bedside for autoim…
Frequently asked questions
- What does the science say about Hair Loss & Hair Growth?
- Understanding and combating hair thinning, pattern baldness, and promoting regrowth through supplements, devices, and lifestyle strategies.
- Which health influencers are most reliable on Hair Loss & Hair Growth?
- Our expert leaderboard ranks influencers by accuracy on Hair Loss & Hair Growth claims, verified against peer-reviewed studies.
All health topics